These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4459869)

  • 1. [Letter: Prolactin and breast cancer].
    Rolandi E; Barreca T; Masturzo P; Polleri A; Indiveri F; Barabino A
    Nouv Presse Med; 1974 Dec; 3(45):2743. PubMed ID: 4459869
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood prolactin level of breast and endometrial cancer patients during surgical intervention].
    Pozdniakov VV; Bobrov IuF; Gamaiunova VB; Evtiukhin AI; Frid IA
    Vopr Onkol; 1984; 30(2):9-14. PubMed ID: 6702135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pituitary hormone level in breast cancer patients].
    Agranat VZ; Valiura AV; Nikogosian GA
    Med Radiol (Mosk); 1981 Mar; 26(3):3-8. PubMed ID: 6783807
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prolactin. Radioimmunoassay in female breast cancers and benign mastopathies].
    Gorins A; Netter A
    Nouv Presse Med; 1974 Jan; 3(2):73-5. PubMed ID: 4815434
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
    Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
    Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in prolactin plasma levels in relation to menopausal status in primary breast carcinoma].
    Pavić S; Pavić Z
    Med Pregl; 1995; 48(5-6):159-61. PubMed ID: 7565335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of blood prolactin levels in breast diseases using prolactin radioimmunoassay kits (CIS-Prolak Kit)].
    Nakajima K; Saito K; Tobioka M; Ishihara K; Kobayashi T
    Horumon To Rinsho; 1976 Dec; 24(12):1303-10. PubMed ID: 1035518
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prolactin and cancer of the breast].
    Marugo M; Giusti M; Bolognesi F; Reitano A
    Boll Soc Ital Biol Sper; 1977 Apr; 53(8):675-8. PubMed ID: 907746
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dynamics of gonadotropins and prolactin in dysplasias and cancer of the breast].
    Korolev VI; Skliar SIu; Ponomarev IN
    Vrach Delo; 1988 Jan; (1):59-61. PubMed ID: 3363942
    [No Abstract]   [Full Text] [Related]  

  • 10. [Correlations between prolactin and somatotropic hormone in human breast cancer].
    Larrad Jiménez A; Caballero Asensi A; Estévez Molina M
    Rev Esp Oncol; 1980; 27(1):29-52. PubMed ID: 7209107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Plasma-prolactin in breast cancer.
    Rolandi E; Barreca T; Masturzo P; Polleri A; Indiveri F; Barabino A
    Lancet; 1974 Oct; 2(7884):845-6. PubMed ID: 4138369
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
    J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin serum level in patients with breast cancer.
    Cohen AD; Cohen Y; Maislos M; Buskila D
    Isr Med Assoc J; 2000 Apr; 2(4):287-9. PubMed ID: 10804904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
    Tworoger SS; Sluss P; Hankinson SE
    Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of serum prolactin determination in metastatic breast cancer patients.
    Mujagić Z; Mujagić H
    Croat Med J; 2004 Apr; 45(2):176-80. PubMed ID: 15103755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood prolactin levels and functional status of the sympatho-adrenal system during complex treatment of breast cancer].
    Sidorenko LN; Korovin KF; Popova SP; Egor'kova AS; Shpanskaia LS
    Vestn Khir Im I I Grek; 1982 Aug; 129(8):13-5. PubMed ID: 7135749
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
    Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of plasma prolactin in patients with breast dysplasia].
    Vázquez Albaladejo C; Ferrer S; Merle S; Sanchis V; Camps Roig J; Giménez Climent J
    Rev Esp Oncol; 1983; 30(3):323-36. PubMed ID: 6571376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlations between PRL and 17-beta-E in human breast cancer].
    Larrad Jiménez A; Ruiz-Tartas A; Zapatero Gaviria J; López Lazareno N
    Rev Esp Oncol; 1984; 31(2):279-87. PubMed ID: 6549590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
    Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.